Pancreatic Cancer Research

Journal articleAnticancer Res2014

Congestive heart failure secondary to gemcitabine nab-paclitaxel in patients with pancreatic cancer.

Journal
Anticancer Res
Published
1 December 2014
Citations
6
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Background Gemcitabine plus nab-paclitaxel is a novel combination chemotherapy that is currently being used in patients with metastatic pancreatic cancer. Phase III trials have shown improved survival, response rates, and disease-free progression. … Excerpt only: this text is the publisher’s. Read it in full at the source.